Friday, November 08, 2024
Advertisement
Published on: May 08, 2021 17:45 IST

Ground Report: DCGI gives emergency approval to DRDO-developed anti-Covid drug

The Drugs Controller General of India has approved an anti-COVID oral drug, developed by DRDO, for emergency use as adjunct therapy in moderate to severe coronavirus patients, the defence ministry said on Saturday. It said clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
Advertisement
Advertisement
Advertisement
Advertisement